FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3109794728> ?p ?o ?g. }

• W3109794728 endingPage "E7" @default.
• W3109794728 startingPage "E7" @default.
• W3109794728 abstract "OBJECTIVE COVID-19 has affected surgical practice globally. Treating neurosurgical patients with the restrictions imposed by the pandemic is challenging in institutions with shared patient areas. The present study was performed to assess the changing patterns of neurosurgical cases, the efficacy of repeated testing before surgery, and the prevalence of COVID-19 in asymptomatic neurosurgical inpatients. METHODS Cases of non–trauma-related neurosurgical patients treated at the Postgraduate Institute of Medical Education and Research (PGIMER) before and during the COVID-19 pandemic were reviewed. During the pandemic, all patients underwent a nasopharyngeal swab reverse transcription–polymerase chain reaction test to detect COVID-19 at admission. Patients who needed immediate intervention were surgically treated following a single COVID-19 test, while stable patients who initially tested negative for COVID-19 were subjected to repeated testing at least 5 days after the first test and within 48 hours prior to the planned surgery. The COVID-19 positivity rate was compared with the local period prevalence. The number of patients who tested positive at the second test, following a negative first test, was used to determine the probable number of people who could have become infected during the surgical procedure without second testing. RESULTS Of the total 1769 non–trauma-related neurosurgical patients included in this study, a mean of 337.2 patients underwent surgery per month before COVID-19, while a mean of 184.2 patients (54.6% of pre–COVID-19 capacity) underwent surgery per month during the pandemic period, when COVID-19 cases were on the rise in India. There was a significant increase in the proportion of patients undergoing surgery for a ruptured aneurysm, stroke, hydrocephalus, and cerebellar tumors, while the number of patients seeking surgery for chronic benign diseases declined. At the first COVID-19 test, 4 patients (0.48%) tested were found to have the disease, a proportion 3.7 times greater than that found in the local community. An additional 5 patients tested positive at the time of the second COVID-19 test, resulting in an overall inpatient period prevalence of 1%, in contrast to a 0.2% national cumulative caseload. It is possible that COVID-19 was prevented in approximately 67.4 people every month by using double testing. CONCLUSIONS COVID-19 has changed the pattern of neurosurgical procedures, with acute cases dominating the practice. Despite the fact that the pandemic has not yet reached its peak in India, COVID-19 has been detected 3.7 times more often in asymptomatic neurosurgical inpatients than in the local community, even with single testing. Double testing displays an incremental value by disclosing COVID-19 overall in 1 in 100 inpatients and thus averting its spread through neurosurgical services." @default.
• W3109794728 created "2020-12-07" @default.
• W3109794728 creator A5000891355 @default.
• W3109794728 creator A5007158075 @default.
• W3109794728 creator A5010404742 @default.
• W3109794728 creator A5017545258 @default.
• W3109794728 creator A5020993226 @default.
• W3109794728 creator A5021423708 @default.
• W3109794728 creator A5026887827 @default.
• W3109794728 creator A5036293272 @default.
• W3109794728 creator A5045590176 @default.
• W3109794728 creator A5059466035 @default.
• W3109794728 creator A5062394508 @default.
• W3109794728 creator A5063448317 @default.
• W3109794728 creator A5064391849 @default.
• W3109794728 creator A5067185856 @default.
• W3109794728 creator A5072048792 @default.
• W3109794728 creator A5072569975 @default.
• W3109794728 creator A5088498181 @default.
• W3109794728 date "2020-12-01" @default.
• W3109794728 modified "2023-09-26" @default.
• W3109794728 title "COVID-19: changing patterns among neurosurgical patients from North India, efficacy of repeat testing, and inpatient prevalence" @default.
• W3109794728 cites W1872009629 @default.
• W3109794728 cites W2028587747 @default.
• W3109794728 cites W2091891877 @default.
• W3109794728 cites W2613979173 @default.
• W3109794728 cites W2901073716 @default.
• W3109794728 cites W3004912618 @default.
• W3109794728 cites W3007497549 @default.
• W3109794728 cites W3012696672 @default.
• W3109794728 cites W3013640245 @default.
• W3109794728 cites W3014615840 @default.
• W3109794728 cites W3014842906 @default.
• W3109794728 cites W3015234525 @default.
• W3109794728 cites W3015337742 @default.
• W3109794728 cites W3016847370 @default.
• W3109794728 cites W3016958495 @default.
• W3109794728 cites W3018287609 @default.
• W3109794728 cites W3018826558 @default.
• W3109794728 cites W3020838251 @default.
• W3109794728 cites W3021968690 @default.
• W3109794728 cites W3022805999 @default.
• W3109794728 cites W3023957973 @default.
• W3109794728 cites W3024958080 @default.
• W3109794728 cites W3031404888 @default.
• W3109794728 cites W3040858457 @default.
• W3109794728 cites W3043589835 @default.
• W3109794728 cites W3045929994 @default.
• W3109794728 doi "https://doi.org/10.3171/2020.9.focus20705" @default.
• W3109794728 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33260131" @default.
• W3109794728 hasPublicationYear "2020" @default.
• W3109794728 type Work @default.
• W3109794728 sameAs 3109794728 @default.
• W3109794728 citedByCount "18" @default.
• W3109794728 countsByYear W31097947282020 @default.
• W3109794728 countsByYear W31097947282021 @default.
• W3109794728 countsByYear W31097947282022 @default.
• W3109794728 crossrefType "journal-article" @default.
• W3109794728 hasAuthorship W3109794728A5000891355 @default.
• W3109794728 hasAuthorship W3109794728A5007158075 @default.
• W3109794728 hasAuthorship W3109794728A5010404742 @default.
• W3109794728 hasAuthorship W3109794728A5017545258 @default.
• W3109794728 hasAuthorship W3109794728A5020993226 @default.
• W3109794728 hasAuthorship W3109794728A5021423708 @default.
• W3109794728 hasAuthorship W3109794728A5026887827 @default.
• W3109794728 hasAuthorship W3109794728A5036293272 @default.
• W3109794728 hasAuthorship W3109794728A5045590176 @default.
• W3109794728 hasAuthorship W3109794728A5059466035 @default.
• W3109794728 hasAuthorship W3109794728A5062394508 @default.
• W3109794728 hasAuthorship W3109794728A5063448317 @default.
• W3109794728 hasAuthorship W3109794728A5064391849 @default.
• W3109794728 hasAuthorship W3109794728A5067185856 @default.
• W3109794728 hasAuthorship W3109794728A5072048792 @default.
• W3109794728 hasAuthorship W3109794728A5072569975 @default.
• W3109794728 hasAuthorship W3109794728A5088498181 @default.
• W3109794728 hasBestOaLocation W31097947281 @default.
• W3109794728 hasConcept C126322002 @default.
• W3109794728 hasConcept C12770488 @default.
• W3109794728 hasConcept C141071460 @default.
• W3109794728 hasConcept C194828623 @default.
• W3109794728 hasConcept C2777910003 @default.
• W3109794728 hasConcept C2779134260 @default.
• W3109794728 hasConcept C3007834351 @default.
• W3109794728 hasConcept C3008058167 @default.
• W3109794728 hasConcept C524204448 @default.
• W3109794728 hasConcept C71924100 @default.
• W3109794728 hasConcept C89623803 @default.
• W3109794728 hasConceptScore W3109794728C126322002 @default.
• W3109794728 hasConceptScore W3109794728C12770488 @default.
• W3109794728 hasConceptScore W3109794728C141071460 @default.
• W3109794728 hasConceptScore W3109794728C194828623 @default.
• W3109794728 hasConceptScore W3109794728C2777910003 @default.
• W3109794728 hasConceptScore W3109794728C2779134260 @default.
• W3109794728 hasConceptScore W3109794728C3007834351 @default.
• W3109794728 hasConceptScore W3109794728C3008058167 @default.
• W3109794728 hasConceptScore W3109794728C524204448 @default.
• W3109794728 hasConceptScore W3109794728C71924100 @default.
• W3109794728 hasConceptScore W3109794728C89623803 @default.

• next